Atlas Trials

Clinical Trial to Evaluate the Efficacy and Safety of Naftopidil in Male Patients With Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia

Clinical trial NCT01922375 · COMPLETED

Trial details

NCT number
NCT01922375
Sponsor
Dong-A Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia
Start date
2011-12-01
Primary completion
2012-09-01
Enrollment
411

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.